World Pharma Today recently featured Inorganic Ventures in the article, "Trace-Level Testing, Validation Pressure, and the New Demands on Pharma Labs," written by Brian Alexander, PhD, president of Inorganic Ventures, examining how pharmaceutical labs are adapting to tighter impurity thresholds and faster development timelines. (worldpharmatoday.com)
The article explores how sample preparation, digestion, calibration alignment, traceability, and method validation all influence whether elemental impurity data can withstand regulatory scrutiny — and why laboratories rely heavily on certified reference materials and calibration standards to establish traceable instrument r












